Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Parental and societal support for adolescent immunization through school based immunization programsMarshall, H.; Collins, J.; Sullivan, T.; Tooher, R.; O'Keefe, M.; Skinner, S.; Watson, M.; Burgess, T.; Ashmeade, H.; Braunack-Mayer, A.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2013Community knowledge, behaviours and attitudes about the 2009 H1N1 influenza pandemic: a systematic reviewTooher, R.; Collins, J.; Street, J.; Braunack-Mayer, A.; Marshall, H.
2013Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative studyParrella, A.; Braunack-Mayer, A.; Gold, M.; Marshall, H.; Baghurst, P.
2013The pertussis epidemic: informing strategies for prevention of severe diseaseClarke, M.; Rasiah, K.; Copland, J.; Watson, M.; Koehler, A.; Dowling, K.; Marshall, H.
2013Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaMarshall, H.; McIntyre, P.; Richmond, P.; Buttery, J.; Royle, J.; Gold, M.; Wood, N.; Elliott, E.; Zurynski, Y.; Toi, C.; Dwyer, D.; Booy, R.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2013A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescentsNissen, M.; Marshall, H.; Richmond, P.; Jiang, Q.; Harris, S.; Jones, T.; Jansen, K.; Perez, J.
2013A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adultsMarshall, H.; Richmond, P.; Nissen, M.; Wouters, A.; Baber, J.; Jiang, Q.; Anderson, A.; Jones, T.; Harris, S.; Jansen, K.; Perez, J.
2013Parental perspectives of vaccine safety and experience of adverse events following immunisationParrella, A.; Gold, M.; Marshall, H.; Braunack-Mayer, A.; Baghurst, P.